404 related articles for article (PubMed ID: 16304054)
1. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.
Rauova L; Zhai L; Kowalska MA; Arepally GM; Cines DB; Poncz M
Blood; 2006 Mar; 107(6):2346-53. PubMed ID: 16304054
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies.
Arepally GM; Kamei S; Park KS; Kamei K; Li ZQ; Liu W; Siegel DL; Kisiel W; Cines DB; Poncz M
Blood; 2000 Mar; 95(5):1533-40. PubMed ID: 10688805
[TBL] [Abstract][Full Text] [Related]
3. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
4. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
[TBL] [Abstract][Full Text] [Related]
5. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
6. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody.
Li ZQ; Liu W; Park KS; Sachais BS; Arepally GM; Cines DB; Poncz M
Blood; 2002 Feb; 99(4):1230-6. PubMed ID: 11830470
[TBL] [Abstract][Full Text] [Related]
7. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
8. Dynamic antibody-binding properties in the pathogenesis of HIT.
Sachais BS; Litvinov RI; Yarovoi SV; Rauova L; Hinds JL; Rux AH; Arepally GM; Poncz M; Cuker A; Weisel JW; Cines DB
Blood; 2012 Aug; 120(5):1137-42. PubMed ID: 22577175
[TBL] [Abstract][Full Text] [Related]
9. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia.
Vayne C; Nguyen TH; Rollin J; Charuel N; Poupon A; Pouplard C; Normann N; Gruel Y; Greinacher A
Thromb Haemost; 2021 Mar; 121(3):322-331. PubMed ID: 33086397
[TBL] [Abstract][Full Text] [Related]
10. Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.
Johnston I; Sarkar A; Hayes V; Koma GT; Arepally GM; Chen J; Chung DW; López JA; Cines DB; Rauova L; Poncz M
Blood; 2020 Apr; 135(15):1270-1280. PubMed ID: 32077913
[TBL] [Abstract][Full Text] [Related]
11. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
12. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
13. Distinct specificity and single-molecule kinetics characterize the interaction of pathogenic and non-pathogenic antibodies against platelet factor 4-heparin complexes with platelet factor 4.
Litvinov RI; Yarovoi SV; Rauova L; Barsegov V; Sachais BS; Rux AH; Hinds JL; Arepally GM; Cines DB; Weisel JW
J Biol Chem; 2013 Nov; 288(46):33060-70. PubMed ID: 24097975
[TBL] [Abstract][Full Text] [Related]
14. Atomic description of the immune complex involved in heparin-induced thrombocytopenia.
Cai Z; Yarovoi SV; Zhu Z; Rauova L; Hayes V; Lebedeva T; Liu Q; Poncz M; Arepally G; Cines DB; Greene MI
Nat Commun; 2015 Sep; 6():8277. PubMed ID: 26391892
[TBL] [Abstract][Full Text] [Related]
15. Platelet and monocyte antigenic complexes in the pathogenesis of heparin-induced thrombocytopenia (HIT).
Rauova L; Arepally G; McKenzie SE; Konkle BA; Cines DB; Poncz M
J Thromb Haemost; 2009 Jul; 7 Suppl 1(0 1):249-52. PubMed ID: 19630810
[TBL] [Abstract][Full Text] [Related]
16. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
Nazy I; Clare R; Staibano P; Warkentin TE; Larché M; Moore JC; Smith JW; Whitlock RP; Kelton JG; Arnold DM
J Thromb Haemost; 2018 Jul; 16(7):1402-1412. PubMed ID: 29723924
[TBL] [Abstract][Full Text] [Related]
17. PF4-HIT antibody (KKO) complexes activate broad innate immune and inflammatory responses.
Haile LA; Rao R; Polumuri SK; Arepally GM; Keire DA; Verthelyi D; Sommers CD
Thromb Res; 2017 Nov; 159():39-47. PubMed ID: 28968537
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes.
Krauel K; Fürll B; Warkentin TE; Weitschies W; Kohlmann T; Sheppard JI; Greinacher A
J Thromb Haemost; 2008 Dec; 6(12):2160-7. PubMed ID: 18983520
[TBL] [Abstract][Full Text] [Related]
19. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.
Reilly MP; Taylor SM; Franklin C; Sachais BS; Cines DB; Williams KJ; McKenzie SE
J Thromb Haemost; 2006 Dec; 4(12):2687-94. PubMed ID: 16961586
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of antibody and antigen in heparin-induced thrombocytopenia.
Newman PM; Chong BH
Br J Haematol; 1999 Nov; 107(2):303-9. PubMed ID: 10583216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
